Bioventix PLC (LON:BVXP – Get Free Report) shares reached a new 52-week low during trading on Monday . The company traded as low as GBX 2,400 ($31.03) and last traded at GBX 2,420 ($31.29), with a volume of 26011 shares changing hands. The stock had previously closed at GBX 2,750 ($35.55).
Bioventix Stock Performance
The business has a 50-day moving average of GBX 2,879.90 and a 200 day moving average of GBX 3,347.62. The stock has a market cap of £125.67 million, a PE ratio of 15.52 and a beta of 0.35.
Bioventix (LON:BVXP – Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.93) EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. Equities analysts expect that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Recommended Stories
- Five stocks we like better than Bioventix
- Growth Stocks: What They Are, What They Are Not
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Short Selling – The Pros and Cons
- The 3 Most Talked About Investments on WallStreetBets Right Now
- NYSE Stocks Give Investors a Variety of Quality Options
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
